Oncology: General

You have access
Head to head comparison of ⁶⁸Ga-NGUL and ⁶⁸Ga-PSMA-11 in patients with metastatic prostate cancer: a prospective study
Minseok Suh, Hyung-Jun Im, Hyun Gee Ryoo, Keon Wook Kang, Jae Min Jeong, Sneha Kumar, SANJANA S BALLAL, Madhav P Yadav, Chandrasekhar Bal, Chang Wook Jeong, Cheol Kwak and Gi Jeong Cheon

Journal of Nuclear Medicine February 26, 2021, jnumed.120.258434; DOI: https://doi.org/10.2967/jnumed.120.258434
You have access
Landscape analysis of phase 2/3 clinical trials of targeted radionuclide therapy
Erik Mittra, Amanda Abbott and Lisa Bodei

Journal of Nuclear Medicine February 12, 2021, jnumed.120.258103; DOI: https://doi.org/10.2967/jnumed.120.258103
You have access
A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806
Hui K Gan, Matthew Burge, Benjamin Solomon, SzeTing Lee, Kyle D Holen, Yumin Zhang, Marika Ciprotti, FT Lee, Wijth Manusinghe, Judee Fischer, Peter Ansell, Gerard Fox, Hao Xiong, Edward B Reilly, Rod Humerickhouse and Andrew M Scott

Journal of Nuclear Medicine January 28, 2021, jnumed.120.253146; DOI: https://doi.org/10.2967/jnumed.120.253146
You have access
Radioguided Surgery (Letter to the Editor)
Giuliano Mariani, Renato A. Valdés Olmos, Sergi Vidal-Sicart and Harry William Strauss

Journal of Nuclear Medicine January 15, 2021, jnumed.120.261888; DOI: https://doi.org/10.2967/jnumed.120.261888
You have access
Pharmacogenomics in Radionuclide Therapy: Impact on Response to Theranostics
Andrew Scott and Lisa Bodei

Journal of Nuclear Medicine December 31, 2020, jnumed.120.254995; DOI: https://doi.org/10.2967/jnumed.120.254995
You have access
Ferronostics: Measuring Tumoral Ferrous Iron with PET to Predict Sensitivity to Iron-Targeted Cancer Therapies
Ning Zhao, Yangjie Huang, Yung-hua Wang, Ryan K Muir, Ying-Chu Chen, Nima Hooshdaran, Junnian Wei, Pavithra Viswanath, Youngho Seo, Davide Ruggero, Adam R Renslo and Michael John Evans

Journal of Nuclear Medicine November 27, 2020, jnumed.120.252460; DOI: https://doi.org/10.2967/jnumed.120.252460
You have access
¹¹C-sorafenib and ¹⁵O-H₂O PET for early evaluation of sorafenib therapy
Lemonitsa H. Mammatas, Maqsood Yaqub, N. Harry Hendrikse, Otto S. Hoekstra, Richard J. Honeywell, Robert C. Schuit, Martijn R. Meijerink, Lothar A. Schwarte, Godefridus J. Peters, Henk M.W. Verheul, Adriaan A. Lammertsma and C. Willemien Menke-van der Houven van Oordt

Journal of Nuclear Medicine October 30, 2020, jnumed.120.251611; DOI: https://doi.org/10.2967/jnumed.120.251611
You have access
Comparison of CD38 targeted alpha- vs beta-radionuclide therapy of disseminated multiple myeloma in an animal model
Megan Minnix, Vikram Adhikarla, Enrico Caserta, Erasmus Poku, Russell Rockne, John E Shively and Flavia Pichiorri

Journal of Nuclear Medicine October 30, 2020, jnumed.120.251983; DOI: https://doi.org/10.2967/jnumed.120.251983
You have access
PET/MRI versus PET/CT for Whole-Body Staging
Stephen K Gerard

Journal of Nuclear Medicine October 9, 2020, jnumed.120.256453; DOI: https://doi.org/10.2967/jnumed.120.256453

Main menu

User menu

Search

Oncology: General